Trial
NCT02011841
Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Spontaneous Bacterial Peritonitis
Intervention
Rifaximin
Why stopped
We failed to recruit patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-25